ストックスクリーナーアプリを入手
66.10
2.02%
1.31
アフターアワーズ：
63.00
-3.10
-4.69%
前日終値:
$64.79
開ける：
$64.75
24時間の取引高:
539.63K
Relative Volume:
2.75
時価総額：
$404.02M
収益：
-
当期純損益:
$-156.09M
株価収益率:
-46.55
EPS:
-1.42
ネットキャッシュフロー:
$-102.69M
1週間 パフォーマンス:
+122.93%
1か月 パフォーマンス:
+557.06%
6か月 パフォーマンス:
+446.28%
1年 パフォーマンス:
+15,308%
1日の値動き範囲:
$60.01
$73.69
1週間の範囲:
$29.50
$92.00
52週間の値動き範囲:
$0.3035
$92.00
Instil Bio Inc Stock (TIL) Company Profile
Instil Bio Inc Stock (TIL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-11-01 | ダウングレード | Cowen | Outperform → Market Perform |
| 2022-11-01 | ダウングレード | Truist | Buy → Hold |
| 2021-08-13 | 開始されました | Robert W. Baird | Outperform |
| 2021-04-13 | 開始されました | Cowen | Outperform |
| 2021-04-13 | 開始されました | Morgan Stanley | Equal-Weight |
| 2021-04-13 | 開始されました | Truist | Buy |
すべてを表示
Instil Bio Inc (TIL) 最新ニュース
The time has not yet come to remove your chips from the table: Instil Bio Inc (TIL) - SETE News
Financial Metrics Unveiled: Instil Bio Inc (TIL)’s Key Ratios in the Spotlight - The Dwinnex
Here's Why Everyone's Talking About Summit Therapeutics - MSN
This is why everyone is talking about Summit TherapeuticsTHE BHARAT EXPRESS NEWS - The Bharat Express News
Here's Why Everyone's Talking About Summit Therapeutics - The Motley Fool
Instil Bio stock target raised by H.C. Wainwright on cancer drug outlook - Investing.com
Baird retains price target, outperform rating on Instil Bio shares - Investing.com India
Crude Oil Surges Over 1%; Instil Bio Shares Plunge - Benzinga
Instil Bio Inc (TIL) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
Instil Bio Stock Skyrockets 641% in One Week: Here's Why - Yahoo Finance
Instil Bio stock target raised by H.C. Wainwright on cancer drug outlook - Investing.com India
Do investors need to be concerned about Instil Bio Inc (TIL)? - US Post News
Instil Bio Outlines Oncology Strategy and Collaborative Efforts - TipRanks
Instil Bio and ImmuneOnco Announce Global Registrational Strategy for PD-L1xVEGF Bispecific Antibody, SYN-2510/IMM2510, in Non-Small Cell Lung Cancer and Triple-Negative Breast Cancer - Yahoo Finance
Up More Than 500% in 2024. Can Instil Bio Keep Rocketing Higher? - sharewise
Up More Than 500% in 2024. Can Instil Bio Keep Rocketing Higher? - The Motley Fool
Baird ups Instil Bio shares target as PD-1/L1xVEGF space gains momentum - Investing.com India
Summit lifts Instil, BioNTech on Merck beating data (NASDAQ:SMMT) - Seeking Alpha
Instil Bio: PD-L1/VEGF Bispecific Targeting With Unique Enhancements (TIL) - Seeking Alpha
Instil Bio surges after Baird target calls for shares tripling - TipRanks
(TIL) On The My Stocks Page - Stock Traders Daily
Instil Bio’s Stock Price Target (NASDAQ: TIL) Get’s A Big Uplift From Baird - AskTraders
Instil Bio price target raised to $180 from $32 at Baird - TipRanks
Baird ups Instil Bio shares target as PD-1/L1xVEGF space gains momentum - Investing.com Australia
Baird ups Instil Bio shares target as PD-1/L1xVEGF space gains momentum - Investing.com
Baird ups Instil Bio shares target as PD-1/L1xVEGF space gains momentum - Investing.com UK
H.C. Wainwright raises share target for Instil Bio by US$15 - Mugglehead
H.C. Wainwright raises Instil Bio shares target with Buy rating - Investing.com
Instil Bio Surges After Another Price-Target Boost - MarketWatch
Instil Bio (TIL) Surges on Promising Cancer Therapy Licensing Deal - BP Journal
Summit Therapeutics Secures $235 Million in Funding from Leading Biotech Investors - BP Journal
H.C. Wainwright raises Instil Bio shares target with Buy rating - Investing.com India
H.C. Wainwright raises Instil Bio shares target with Buy rating By Investing.com - Investing.com UK
Exact Sciences To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga
A stock that deserves closer examination: Instil Bio Inc (TIL) - US Post News
Private equity firms are Instil Bio, Inc.'s (NASDAQ:TIL) biggest owners and were rewarded after market cap rose by US$52m last week - Yahoo Finance
TIL’s Stochastic Averages Dip: Analyzing Instil Bio Inc’s Stock Performance - The InvestChronicle
United States shares higher at close of trade; Dow Jones Industrial Average up 1.20% - MSN
Instil Bio stock soars to 52-week high, hits $16.4 - Investing.com
Instil Bio shares positive on external trial data, Baird maintains price target - Investing.com
Instil Bio Shares Rise After Exiting Operations in Manchester, U.K. - MarketWatch
Instil Bio announces closure of UK operations - Investing.com
Instil Bio Exiting Manchester, UK, Operations and Eliminating Workforce - MarketWatch
Instil Bio stock soars to 52-week high, reaches $13.95 - Investing.com India
Instil Bio stock soars to 52-week high, reaches $13.95 By Investing.com - Investing.com Canada
Applied DNA Sciences Inc. (NASDAQ: APDN): Expanding Horizons in DNA Technology and Clinical Testing - BP Journal
Learn to Evaluate (TIL) using the Charts - Stock Traders Daily
Instil Bio Presents Latest Updates with Investor Disclaimer - TipRanks
TIL Stock Earnings: Instil Bio Beats EPS for Q2 2024 - MSN
TIL Stock Earnings: Instil Bio Beats EPS for Q2 2024 - InvestorPlace
Instil Bio Reports Second Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire
Instil Bio Inc (TIL) 財務データ
収益
当期純利益
現金流量
EPS
0.87%
1.31%
大文字化:
|
ボリューム (24 時間):